High seroprevalence for SARS-CoV-2 infection in South America, but still not enough for herd immunity!

Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence

(2021) Ester C Sabino et al.   LANCET

Time-dependent heterogeneity leads to transient suppression of the COVID-19 epidemic, not herd immunity

(2021) Alexei V. Tkachenko et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

SARS-CoV-2 vaccines: A critical perspective through efficacy data and barriers to herd immunity

(2021) Francesco Blasi et al.   RESPIRATORY MEDICINE

Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Peru in July and August, 2020: a population-based study

(2021) Carlos Álvarez-Antonio et al.   Lancet Global Health

SARS-CoV-2 seroprevalence study in Lambayeque, Peru. June–July 2020

(2021) Cristian Díaz-Vélez et al.   PeerJ

Dramatic rise in seroprevalence rates of SARS-CoV-2 antibodies among healthy blood donors: The evolution of a pandemic

(2021) Maher A. Sughayer et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

SARS-CoV-2 Variants: A Synopsis of In Vitro Efficacy Data of Convalescent Plasma, Currently Marketed Vaccines, and Monoclonal Antibodies

(2021) Daniele Focosi et al.   Viruses-Basel

Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China

(2020) Xin Xu et al.   NATURE MEDICINE

Population-based surveys of antibodies against SARS-CoV-2 in Southern Brazil

(2020) Mariângela F. Silveira et al.   NATURE MEDICINE

SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis

(2020) A. Rostami et al.   CLINICAL MICROBIOLOGY AND INFECTION

Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans

(2020) Jeffrey Seow et al.   Nature Microbiology

Estimating the herd immunity threshold by accounting for the hidden asymptomatics using a COVID-19 specific model

(2020) Shaurya Kaushal et al.   PLoS One